Looking for something specific?
At 9M India Limited, trust through quality, transparency, performance.
About
9M India manufactures a comprehensive range of cardiovascular hard gelatin capsules at its WHO-GMP certified facility in Birkoni, Chhattisgarh. Cardiovascular disease is the leading cause of mortality globally, driving consistent and large-volume demand for antihypertensives, lipid-lowering agents, anticoagulants and antianginal formulations across all export markets. Our cardiovascular capsule portfolio covers calcium channel blockers, statins, beta-blockers, ACE inhibitors, ARBs, anticoagulants and combination formulations — all manufactured to BP/USP pharmacopoeial standards with full in-house analytical testing, stability data and export documentation.

Our cardiovascular drugs capsule range covers the following sub-categories and key molecules:
| Sub-Category | Key Molecules |
| Antihypertensives | Amlodipine 5mg / 10mg, Atenolol 50mg / 100mg, Bisoprolol 5mg, Carvedilol 6.25mg / 12.5mg |
| Lipid-Lowering Agents | Rosuvastatin 10mg / 20mg, Atorvastatin 10mg / 20mg / 40mg, Fenofibrate 200mg |
| Anti-coagulants | Warfarin Sodium 1mg / 5mg, Aspirin 75mg / 100mg / 150mg |
| Antianginals | Isosorbide Dinitrate 10mg, Nitroglycerin SR 2.6mg, Amlodipine 5mg / 10mg |
| ACE Inhibitors | Enalapril 5mg / 10mg, Lisinopril 5mg / 10mg, Ramipril 2.5mg / 5mg |
| ARBs | Losartan 50mg, Telmisartan 40mg / 80mg, Valsartan 80mg |
| Combination Products | Amlodipine + Atenolol, Amlodipine + Losartan, Rosuvastatin + Atorvastatin |
WHY 9M INDIA FOR CARDIOVASCULAR DRUGS
9M India manufactures across every major cardiovascular sub-class — from antihypertensives and statins to anticoagulants and combination fixed-dose products. Buyers can source multiple cardiovascular molecules from a single WHO-GMP certified supplier, simplifying procurement and regulatory management.
Beyond standalone molecules, 9M India manufactures combination cardiovascular capsules — Amlodipine + Atenolol, Amlodipine + Losartan, and others — in a single dosage unit. These improve patient compliance for chronic cardiovascular disease management and command better market positioning.
All cardiovascular capsule formulations are supported by WHO-GMP Certificate, CoPP, batch CoA, ICH Zone IVb stability data and CTD/ACTD dossiers on request — covering the full documentation package required for market registration in the Middle East, CIS, Africa and ASEAN.
Molecule Grid
Amlodipine 5mg / 10mg | Antihypertensive | Hard gelatin capsule | Calcium Channel Blocker
Atenolol 50mg / 100mg | Antihypertensive | Hard gelatin capsule | Beta-Blocker
Rosuvastatin 10mg / 20mg | Lipid-Lowering | Hard gelatin capsule | Statin
Atorvastatin 10mg / 20mg / 40mg | Lipid-Lowering | Hard gelatin capsule | Statin
Warfarin Sodium 1mg / 5mg | Anticoagulant | Hard gelatin capsule | Vitamin K Antagonist
Enalapril Maleate 5mg / 10mg | Antihypertensive | Hard gelatin capsule | ACE Inhibitor
Losartan Potassium 50mg | Antihypertensive | Hard gelatin capsule | ARB
Carvedilol 6.25mg / 12.5mg | Antihypertensive / Heart Failure | Hard gelatin capsule | Alpha-Beta Blocker
Bisoprolol Fumarate 5mg | Antihypertensive / Heart Failure | Hard gelatin capsule | Beta-Blocker
Amlodipine + Atenolol | Antihypertensive combination | Hard gelatin capsule | CCB + Beta-Blocker
Export markets & regulatory
9M India exports cardiovascular capsules to 15+ countries across Phase 1 markets including the UAE, Iraq, Egypt, Mexico, Russia, Kazakhstan and others in the Middle East, CIS, Africa, ASEAN and Latin America. Cardiovascular medicines represent one of the highest-volume export categories globally and form a core part of our international supply portfolio.
WHO-GMP Certificate
DCGI Manufacturing Licence
Certificate of Pharmaceutical Product (CoPP)
Certificate of Analysis (CoA) — batch-wise
CTD / ACTD Dossier — on request
Stability Data — ICH Zone IVb (30°C/75% RH)
Whether you are sourcing antihypertensives, lipid-lowering agents or anticoagulant capsules — for institutional supply, government tenders or export distribution — 9M India can fulfil your requirement with WHO-GMP certified manufacturing, full documentation and reliable supply.
WHO-GMP
Certified
1,000+
Formulations
15+ Countries
Supplied
DCGI
Approved
Therapeutic Categories
Our capsule portfolio covers the therapeutic areas with the highest demand across domestic distribution, institutional supply and international export markets.
We keep answer short
01
9M India manufactures a broad cardiovascular capsule range including antihypertensives (Amlodipine, Atenolol, Bisoprolol, Carvedilol, Enalapril, Losartan, Telmisartan), lipid-lowering agents (Rosuvastatin, Atorvastatin), anticoagulants (Warfarin, Aspirin) and combination fixed-dose products. All are manufactured at our WHO-GMP certified facility in Birkoni, Chhattisgarh.
02
Yes. 9M India manufactures several cardiovascular combination formulations including Amlodipine + Atenolol, Amlodipine + Losartan and Rosuvastatin + Atorvastatin. Fixed-dose combination capsules improve patient compliance and are in growing demand across export markets for chronic disease management.
03
Yes. Cardiovascular medicines are part of 9M India's institutional and government supply programme. We support large-volume tender procurement with flexible packaging formats, complete GMP documentation, CoPP and batch CoA. Please contact our export team with tender specifications.
04
9M India provides WHO-GMP Certificate, DCGI Manufacturing Licence, Certificate of Pharmaceutical Product (CoPP), batch-wise Certificate of Analysis, ICH Zone IVb stability data and CTD/ACTD dossiers on request for all cardiovascular capsule formulations.
05
9M India exports cardiovascular capsules to Phase 1 markets including the UAE, Iraq, Egypt, Mexico, Russia, Kazakhstan, Jordan, Sri Lanka and others across the Middle East, CIS, Africa and ASEAN. Cardiovascular formulations are one of the highest-demand categories across all our active export markets.